Publications by authors named "Barry D Hock"

Claim this Profile
I
Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1.
Barry D Hock, Liping Goddard, Lachlan J Dobson, Sean A MacPherson, John L O'Donnell

Cancer Immunol Immunother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory.
Paula Elizabeth Keating, Barry D Hock, Paul K L Chin, John Liston O'Donnell, Murray Lindsay Barclay

Ther Drug Monit· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.
Paula E Keating, Barry D Hock, Stewart M Smith, Paul K L Chin, John L O'Donnell

Intern Med J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab.
Barry D Hock, Liping Goddard, Sean A MacPherson, Matthew Strother, David Gibbs

PLoS One· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Chitinase 3-Like 1 in Symptomatic Primary Care Patient Faecal Samples is Not a Reliable Biomarker of Colonic Lesions.
Jacqueline I Keenan, Alan Aitchison, Frank A Frizelle, Barry D Hock

Asian Pac J Cancer Prev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD36 down regulation by the macrophage antioxidant 7,8-dihydroneopterin through modulation of PPAR-γ activity.
Nooshin Ghodsian, Anthony Yeandle, Barry D Hock, Steven P Gieseg

Free Radic Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies.
Barry D Hock, Judith L McKenzie, Matthew Strother, Liping Goddard, Leah Butt

Cancer Immunol Immunother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neopterin formation through radical scavenging of superoxide by the macrophage synthesised antioxidant 7,8-dihydroneopterin.
Gregory Baxter-Parker, Hannah M Prebble, Sean Cross, Nina Steyn, Anastasia Shchepetkina, Barry D Hock

Free Radic Biol Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of anti-natalizumab antibodies by homogeneous mobility shift assay.
Paula E Keating, Roderick Duncan, Myfanwy Spellerberg, John O'Donnell, Barry D Hock

Pathology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.
Barry D Hock, Stewart M Smith, Christopher J McEntyre, Judith L McKenzie, Christiaan Sies

J Immunol Methods· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of human papillomavirus infection and leukaemic infiltrate in cutaneous squamous cell carcinoma from patients with chronic lymphocytic leukaemia.
Rachel V Purcell, Barry D Hock, Jacqui Gardner, Liping Goddard, Sean A MacPherson

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre.
Barry D Hock, Katie S Mulholland, Peter Ganly, Judith L McKenzie, John F Pearson

Intern Med J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution Assay.
Barry D Hock, Judith L McKenzie, Liping Goddard, Stewart M Smith, Christopher J McEntyre

Ther Drug Monit· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.
Barry D Hock, Sean A MacPherson, Judith L McKenzie

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 7,8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages.
Anastasia A Shchepetkina, Barry D Hock, Allison Miller, Martin A Kennedy, Steven P Gieseg

Int J Biochem Cell Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helicobacter pylori outer membrane vesicles inhibit human T cell responses via induction of monocyte COX-2 expression.
Barry D Hock, Judith L McKenzie, Jacqueline I Keenan

Pathog Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an ELISA-Based Competitive Binding Assay for the Analysis of Drug Concentration and Antidrug Antibody Levels in Patients Receiving Adalimumab or Infliximab.
Barry D Hock, Lisa K Stamp, Matthew W Hayman, Paula E Keating, Esther T J Helms

Ther Drug Monit· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.
Barry D Hock, Judith L McKenzie, Nicholas B Cross, Margaret J Currie

Transpl Immunol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of CD3/CD28 antibody stimulated responses by human granulocytic myeloid-derived suppressor cells: fact or artefact?
Barry D Hock, Judith L McKenzie

Immunol Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability.
Barry D Hock, Karen G Taylor, Nicholas B Cross, Anthony J Kettle, Mark B Hampton

Immunology· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
Barry D Hock, Katarzyna A Mackenzie, Nicholas B Cross, Karen G Taylor, Margaret J Currie

Nephrol Dial Transplant· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.
Katarzyna Anna Mackenzie, Andrew Peter Miller, Barry David Hock, Jacqui Gardner, Jeremy William Simcock

Histopathology· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor.
Sarah C Saunderson, Petra C Schuberth, Amy C Dunn, Lilija Miller, Barry D Hock

J Immunol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Barry D Hock, Judith L McKenzie, Nigel W Patton, Mark Drayson, Karen Taylor

Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to the electrofusion process can increase the immunogenicity of human cells.
Barry D Hock, Georgina Roberts, Judith L McKenzie, Prachee Gokhale, Nina Salm

Cancer Immunol Immunother· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis